Northwest Investment Counselors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.17M | Buy |
3,645
+42
| +1% | +$13.7K | 0.27% | 87 |
|
|
2024
Q2 | $1.13M | Hold |
3,603
| – | – | 0.28% | 86 |
|
|
2024
Q1 | $1.02M | Buy |
3,603
+250
| +7% | +$73.2K | 0.25% | 89 |
|
|
2023
Q4 | $966K | Hold |
3,353
| – | – | 0.26% | 87 |
|
|
2023
Q3 | $901K | Buy |
3,353
+6
| +0.2% | +$1.5K | 0.25% | 90 |
|
|
2023
Q2 | $743K | Buy |
3,347
+161
| +5% | +$37.4K | 0.2% | 93 |
|
|
2023
Q1 | $770K | Hold |
3,186
| – | – | 0.21% | 96 |
|
|
2022
Q4 | $837K | Buy |
3,186
+75
| +2% | +$20.1K | 0.24% | 90 |
|
|
2022
Q3 | $701K | Hold |
3,111
| – | – | 0.23% | 95 |
|
|
2022
Q2 | $757K | Sell |
3,111
-8
| -0.3% | -$1.96K | 0.23% | 91 |
|
|
2022
Q1 | $754K | Hold |
3,119
| – | – | 0.2% | 99 |
|
|
2021
Q4 | $702K | Hold |
3,119
| – | – | 0.17% | 102 |
|
|
2021
Q3 | $663K | Buy |
3,119
+33
| +1% | +$7.59K | 0.19% | 100 |
|
|
2021
Q2 | $752K | Buy |
3,086
+50
| +2% | +$12.3K | 0.21% | 95 |
|
|
2021
Q1 | $755K | Hold |
3,036
| – | – | 0.22% | 91 |
|
|
2020
Q4 | $698K | Sell |
3,036
-28
| -0.9% | -$6.46K | 0.22% | 91 |
|
|
2020
Q3 | $779K | Buy |
3,064
+100
| +3% | +$24.8K | 0.27% | 80 |
|
|
2020
Q2 | $699K | Hold |
2,964
| – | – | 0.27% | 85 |
|
|
2020
Q1 | $601K | Buy |
2,964
+8
| +0.3% | +$1.75K | 0.27% | 86 |
|
|
2019
Q4 | $713K | Hold |
2,956
| – | – | 0.25% | 96 |
|
|
2019
Q3 | $572K | Hold |
2,956
| – | – | 0.2% | 109 |
|
|
2019
Q2 | $545K | Hold |
2,956
| – | – | 0.2% | 108 |
|
|
2019
Q1 | $562K | Hold |
2,956
| – | – | 0.22% | 106 |
|
|
2018
Q4 | $575K | Buy |
2,956
+128
| +5% | +$25K | 0.25% | 100 |
|
|
2018
Q3 | $586K | Sell |
2,828
-18
| -0.6% | -$3.55K | 0.23% | 102 |
|
|
2018
Q2 | $525K | Hold |
2,846
| – | – | 0.21% | 104 |
|
|
2018
Q1 | $485K | Hold |
2,846
| – | – | 0.2% | 108 |
|
|
2017
Q4 | $495K | Hold |
2,846
| – | – | 0.2% | 107 |
|
|
2017
Q3 | $531K | Sell |
2,846
-61
| -2% | -$10.8K | 0.23% | 96 |
|
|
2017
Q2 | $501K | Buy |
2,907
+529
| +22% | +$86K | 0.23% | 97 |
|
|
2017
Q1 | $390K | Sell |
2,378
-123
| -5% | -$20.4K | 0.19% | 104 |
|
|
2016
Q4 | $366K | Buy |
2,501
+3
| +0.1% | +$452 | 0.19% | 106 |
|
|
2016
Q3 | $417K | Buy |
2,498
+1
| +0% | +$169 | 0.21% | 104 |
|
|
2016
Q2 | $380K | Buy |
2,497
+40
| +2% | +$6.22K | 0.21% | 105 |
|
|
2016
Q1 | $368K | Buy |
2,457
+63
| +3% | +$9.36K | 0.21% | 106 |
|
|
2015
Q4 | $389K | Buy |
2,394
+2
| +0.1% | +$314 | 0.24% | 100 |
|
|
2015
Q3 | $331K | Buy |
2,392
+1
| +0% | +$158 | 0.22% | 97 |
|
|
2015
Q2 | $367K | Buy |
2,391
+2
| +0.1% | +$320 | 0.23% | 95 |
|
|
2015
Q1 | $382K | Hold |
2,389
| – | – | 0.24% | 93 |
|
|
2014
Q4 | $381K | Buy |
2,389
+300
| +14% | +$46.7K | 0.24% | 91 |
|
|
2014
Q3 | $293K | Hold |
2,089
| – | – | 0.2% | 90 |
|
|
2014
Q2 | $247K | Hold |
2,089
| – | – | 0.17% | 94 |
|
|
2014
Q1 | $258K | Buy |
2,089
+39
| +2% | +$4.73K | 0.18% | 97 |
|
|
2013
Q4 | $234K | Hold |
2,050
| – | – | 0.16% | 101 |
|
|
2013
Q3 | $229K | Hold |
2,050
| – | – | 0.18% | 99 |
|
|
2013
Q2 | $202K | Buy |
+2,050
| New | +$213K | 0.17% | 100 |
|
Other funds holding AMGN
Northwest Investment Counselors's AMGN Position: Q3 2024 in Review
Northwest Investment Counselors increased its Amgen (AMGN) stake by 1.2% in Q3 2024, buying an estimated $13.7K and bringing the position to 3,645 shares worth $1.17M. The position accounts for 0.27% of the portfolio, ranked #87.
Northwest Investment Counselors first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Northwest Investment Counselors held 3,645 shares of Amgen worth $1.17M as of Q3 2024.
- Northwest Investment Counselors bought 42 Amgen shares in Q3 2024, an estimated $13.7K.
- Amgen made up 0.27% of Northwest Investment Counselors's portfolio in Q3 2024, its #87 holding.
- Northwest Investment Counselors first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
- 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.